TimesSquare U.S. Small Cap Growth Strategy highlighted stocks like Reata Pharmaceuticals, Inc. (NASDAQ:RETA) in the second quarter 2023 investor letter.Headquartered in Plano, Texas, Reata ...

Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease ...

Reata RETA announced that the FDA has accepted the Prior Approval Supplement (PAS) to update the drug substance specification for Skyclarys (omaveloxolone).. In February 2023, the company received ...